Maitland-van der Zee, AHKlungel, OHStricker, BHCVerschuren, WMMrivmKastelein, JJPLeufkens, HGMde Boer, A2025-03-182025-03-182002https://rivm.openrepository.com/handle/10029/639425Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitorsArticleAtherosclerosis 2002; 163:213-222025-03-18